Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minghui Yang

Showing results (621-630 of 625) with videos related to

Pageof 63
Sort By:
You have reached the last page of results.This site can display upto 625 results.
The Journal of Allergy and Clinical Immunology|May 4, 2020
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19Yang Yang, Chenguang Shen, Jinxiu Li, et al.
Engineering (Beijing, China)|April 30, 2020
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control StudyQingxian Cai, Minghui Yang, Dongjing Liu, et al.
JAMA|March 29, 2020
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaChenguang Shen, Zhaoqin Wang, Fang Zhao, et al.
The Lancet Regional Health. Western Pacific|April 20, 2026
Factors influencing the implementation of best clinical practices for hip fracture management in resource-constrained hospitals in China and co-design of quality improvement interventions: a qualitative studyTingzhuo Liu, Gang Liu, Ning Tang, et al.
Phenomics (Cham, Switzerland)|October 14, 2024
Expert Consensus on Big Data Collection of Skin and Appendage Disease Phenotypes in ChineseShuang Zhao, Zhongling Luo, Ying Wang, et al.
Pageof 63

Showing results (621-630 of 625) with videos related to

Sort By:
Pageof 63
You have reached the last page of results.This site can display upto 625 results.
The Journal of Allergy and Clinical Immunology|May 4, 2020
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19Yang Yang, Chenguang Shen, Jinxiu Li, et al.
Engineering (Beijing, China)|April 30, 2020
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control StudyQingxian Cai, Minghui Yang, Dongjing Liu, et al.
JAMA|March 29, 2020
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaChenguang Shen, Zhaoqin Wang, Fang Zhao, et al.
The Lancet Regional Health. Western Pacific|April 20, 2026
Factors influencing the implementation of best clinical practices for hip fracture management in resource-constrained hospitals in China and co-design of quality improvement interventions: a qualitative studyTingzhuo Liu, Gang Liu, Ning Tang, et al.
Phenomics (Cham, Switzerland)|October 14, 2024
Expert Consensus on Big Data Collection of Skin and Appendage Disease Phenotypes in ChineseShuang Zhao, Zhongling Luo, Ying Wang, et al.
Pageof 63